"Terrorism has emerged as the most serious scourge of our times and endangers international peace, security and prosperity," First Secretary in the Indian Mission to the UN Mayank Joshi said at a session titled 'Crime Prevention and International Drug Control' at the Third Committee yesterday.
He also noted that "state-sponsored cross-border terrorism is of particular concern to India".
"Any country that allows the perpetrators of dastardly terrorist acts against innocent people, poses a serious threat to all nations," Joshi said in an apparent reference to Pakistan.
He stressed that it is high time for the international community to demonstrate the necessary political will and conclude the Comprehensive Convention on international terrorism to strengthen the normative framework against the increasingly sophisticated and globalised terrorist challenge.
"Increasing threats of cybercrime have the potential of being even more lethal than conventional wars and calls for national capacity building, technical assistance and global cooperation and response.
India strongly advocates that effective and strengthened crime prevention and criminal justice institutions are the cornerstone for establishing rule of law and are essential for peace, progress and prosperity of nations and successful implementation of the Agenda 2030 for sustainable development, he said.
Joshi underscored that the need of the hour is not to dilute the Drug Conventions, but to strengthen their implementation in their spirit and address the drug problem on the basis of principle of common and shared responsibility.
The Special Session at the General Assembly next year is a unique and valuable opportunity to take stock of the achievements and challenges in addressing the world drug problem as envisaged by 2019.
The government has also established a monitoring committee to bring the New Psychoactive Substances (NPS), which now number over 540, and synthetic drugs, under control. India is also moving towards an 'Online regulatory regime' aimed to better serve the victims of drug abuse and patients in need of relief, he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
